Eloxx Pharmaceuticals Inc. (ELOX) Fundamentals

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing novel ribonucleic acid (RNA)-modulating drug candidates that are formulated to treat rare and ultra-rare premature stop codon diseases. The ELX-02, the company's lead investigational drug product candidate, is a small molecule designed to restore the production of full-length functional proteins. The ELX-02, is in the early stages of clinical development for systemic administration for cystic fibrosis and cystinosis.
SHARE INFORMATION
Market Cap$ 12,175,199
Shares Outstanding86,656,221
Float71,567,344
Percent Float82.59%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -0.97
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions70
Institutional Holdings Date2022-10-31
Institutional Bought Previous 3 Months96,869
Institutional Holdings Percent23.2%
Institutional Sold Previous 3 Months685,545
Insider Holdings Date2022-10-31
Insider Bought Previous 3 Months-
Insider Holdings Percent23.2
Insider Sold Previous 3 Months-
Insider Shares Owned20,077,955
TRADING INFO
52 Week High$ 1.01
52 Week Low$ 0.11
52 Week High Change$ -81.27
21 Day Moving Average$ 0.1355
21 Day Extended Moving Average$ 0.138946
50 Day Moving Average$ 0.1534
50 Day Extended Moving Average$ 0.170957
200 Day Moving Average$ 0.31204
200 Day Extended Moving Average$ 0.412602
10 Day Average Volume472,942
20 Day Average Volume332,262
30 Day Average Volume260,985
50 Day Average Volume225,821
Alpha-0.044131
Beta2.1320
Standard Deviation0.251461
R20.201513
7 Day Price Change$ 0.0062
7 Day Percent Change4.62%
21 Day Price Change$ 0.0084
21 Day Percent Change6.36%
30 Day Price Change$ -0.0062
30 Day Percent Change-4.23%
Month to Date Price Change$ -0.0037
Month to Date Percent Change-2.57%
Quarter to Date Price Change$ -0.0295
Quarter to Date Percent Change-17.35%
180 Day Price Change$ -0.186
180 Day Percent Change-56.97%
200 Day Price Change$ -0.1811
200 Day Percent Change-56.31%
Year to Date Price Change$ -0.5657
Year to Date Percent Change-80.1%

Eloxx Pharmaceuticals Inc. (ELOX) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-2.40
Total Debt To Equity7.40
Int Coverage-21.90
Current Ratio1.20
Leverage Ratio5.10
Quick Ratio1.10
Long Term Debt To Capital0.87
VALUATION MEASURES
PE Ratio-0.30
Enterprise Value$ 1,030,199
Price to Sales0.00
Price to Free Cash-0.30
PE High Last 5 Years-1.50
Price To Book6.30
Price To Cash Flow0.00
PE Low Last 5 Years-2.00
Price to Tangible Book-2.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-113.38
Return on Equity-364.24
Return on Capital-145.97

Eloxx Pharmaceuticals Inc. (ELOX) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorDeloitte & Touche LLP
CEOSumit Aggarwal
Emplyoees28
Last AuditUE
CIK0001035354
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address480 Arsenal Way
Watertown, MA 2472
Websitehttp://www.eloxxpharma.com
Facsimile-
Telephone+1 781 577-5300
Emailbarbarar@eloxxpharma.com


Your Recent History
NASDAQ
ELOX
Eloxx Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.